publication date: Dec. 23, 2010

In this issue: 

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

Congress Approves $4.19 Billion For NCI, $23.5 Billion For NIH, In FY2002 Appropriation.

Klausner To Serve As Advisor On Bioterrorism For NAS.

Toxicity Of Salts Regimen Should Remain A Concern.

Download (PDF )

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.